title: Adolescent and young adult cancer survival.
abstract: Adolescent and young adults (AYAs) face challenges in having their cancers recognized, diagnosed, treated, and monitored. Monitoring AYA cancer survival is of interest because of the lack of improvement in outcome previously documented for these patients as compared with younger and older patient outcomes. AYA patients 15-39 years old, diagnosed during 2000-2008 with malignant cancers were selected from the SEER 17 registries data. Selected cancers were analyzed for incidence and five-year relative survival by histology, stage, and receptor subtypes. Hazard ratios were estimated for cancer death risk among younger and older ages relative to the AYA group. AYA survival was worse for female breast cancer (regardless of estrogen receptor status), acute lymphoid leukemia (ALL), and acute myeloid leukemia (AML). AYA survival for AML was lowest for a subtype associated with a mutation of the nucleophosmin 1 gene (NPM1). AYA survival for breast cancer and leukemia remain poor as compared with younger and older survivors. Research is needed to address disparities and improve survival in this age group.
authors.affiliation: Division of Cancer Control and Population Sciences (DRL, AWS, MRS), Division of Cancer Treatment and Diagnosis (NLS), National Cancer Institute, National Institutes of Health, Bethesda, MD. lewisde@mail.nih.gov.
authors.forename: Denise Riedel
authors.initials: DR
authors.lastname: Lewis
authors.affiliation: Division of Cancer Control and Population Sciences (DRL, AWS, MRS), Division of Cancer Treatment and Diagnosis (NLS), National Cancer Institute, National Institutes of Health, Bethesda, MD.
authors.forename: Nita L
authors.initials: NL
authors.lastname: Seibel
authors.affiliation: Division of Cancer Control and Population Sciences (DRL, AWS, MRS), Division of Cancer Treatment and Diagnosis (NLS), National Cancer Institute, National Institutes of Health, Bethesda, MD.
authors.forename: Ashley Wilder
authors.initials: AW
authors.lastname: Smith
authors.affiliation: Division of Cancer Control and Population Sciences (DRL, AWS, MRS), Division of Cancer Treatment and Diagnosis (NLS), National Cancer Institute, National Institutes of Health, Bethesda, MD.
authors.forename: Margaret R
authors.initials: MR
authors.lastname: Stedman
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006301:Health Services Needs and Demand; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000453:epidemiology* / Q000235:genetics / Q000401:mortality*; D000090243:Nucleophosmin; D018426:SEER Program; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D055815:Young Adult